FDA Finalizing Study Protocols For DTC Ad Brief Summary Research
This article was originally published in The Pink Sheet Daily
Executive Summary
In the first of three studies, FDA will examine consumer responses to a mock weight-loss drug ad to determine how and why consumers use the brief summary. Research data will be collected in the spring, but a final guidance on the brief summary content and format “will be awhile,” FDA says.
You may also be interested in...
FDA Goes Online For DTC Brief Summary Research
The agency’s computer-based direct-to-consumer advertising study will allow FDA to learn how much time consumers spend reading the brief summary.
FDA Goes Online For DTC Brief Summary Research
The agency’s computer-based direct-to-consumer advertising study will allow FDA to learn how much time consumers spend reading the brief summary.
FDA Brief Summary Study Would Gauge Patient Perception Of Drug Riskiness
FDA publishes draft protocol for trial to assist in finalizing brief summary guidance. The 432-subject trial would gather patients' perceptions of eight advertisements for low- or high-risk products in four medical conditions.